Julie Turner, APRN
Acute Care · Lexington, KYNPI 1346788023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $970 and has fallen 54.8% since, to $439 in 2025.
Across 17 payments — averaging $100.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$339
- Amgen$250
- Abbott$229
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$191
- Esperion Therapeutics, Inc.$169
- Medtronic$148
- plus $377 from 4 others
What the payments were for
- Food & beverage$1,65197%
- Education$523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $339 |
| Amgen | 2 | $250 |
| Abbott | 2 | $229 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $191 |
| Esperion Therapeutics, Inc. | 2 | $169 |
| Medtronic | 1 | $148 |
| Bayer | 1 | $125 |
| Johnson & Johnson | 1 | $101 |
| Atricure, Inc. | 1 | $99 |
| Biotronik Inc. | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,703 in reported general payments places this provider in the 80th percentile of 319 acute care providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $19,607 |
| Dofetilide | 20 | $3,171 |
| Amiodarone Hcl | 28 | $832 |
| Metoprolol Succinate | 13 | $172 |
| SotalolSotalol Hcl | 20 | $157 |
| Pantoprazole Sodium | 22 | $82 |
| ClopidogrelClopidogrel Bisulfate | 30 | $69 |
| Sucralfate | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other acute care in Lexington
- Billie WaltersLexington$20K
- Audra MarcumLexington$14K
- Holly ChitwoodLexington$10K
- Chadwick HuntLexington$6K
- Nicole ClevingerLexington$5K
- Sara StarksLexington$4K
- Autumn WestmorelandLexington$4K
- Charles BeachLexington$4K
- Lauren DavisLexington$4K
- Alicia ReamsLexington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.